Has Kevin Ghassemi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,081 in general payments to Kevin Ghassemi, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kevin Ghassemi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kevin Ghassemi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kevin Ghassemi, MD

Gastroenterology · Los Angeles, CANPI 1508062654

Payments from drug & device makers

$1,081in general payments, 2019–2025

Across 12 payments — averaging $90.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Fujifilm Healthcare Americas Corporation$526
Olympus America Inc.$190
AbbVie$141
Regeneron Healthcare Solutions, Inc.$95
Sanofi$72
Medtronic$42
plus $15 from 1 others

What the payments were for

Food & beverage$1,081100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Fujifilm Healthcare Americas Corporation	3	$526
Olympus America Inc.	1	$190
AbbVie	2	$141
Regeneron Healthcare Solutions, Inc.	1	$95
Sanofi	2	$72
Medtronic	2	$42
Cook Medical LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,081 in reported general payments places this provider in the 35th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024

$243,370

Medicare patients

767

Services billed

1,842

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MotegrityPrucalopride Succinate	78	$61,681
CreonLipase/Protease/Amylase	49	$57,929
Dexlansoprazole DrDexlansoprazole	83	$20,470
LinzessLinaclotide	26	$17,453
TrulancePlecanatide	30	$17,319
Mesalamine	22	$7,576
MovantikNaloxegol Oxalate	12	$7,080
Omeprazole	375	$4,785
Colestipol Hcl	16	$3,655
Esomeprazole Magnesium	50	$3,403
Lubiprostone	34	$3,000
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	44	$2,963
Desipramine Hcl	106	$2,679
Famotidine	120	$1,590
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine	30	$1,413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieCreon, Linzess	$141	$75,38375 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,885 gastroenterology providers in California.

Other gastroenterology in Los Angeles

Gil MelmedLos Angeles$3M
Bennett RothLos Angeles$2.8M
Sammy SaabLos Angeles$2M
Caroline HwangLos Angeles$908K
Andres YarurLos Angeles$903K
Brennan SpiegelLos Angeles$845K
Nicholas KaryotakisLos Angeles$710K
Venkataraman MuthusamyLos Angeles$693K
Sadeea AbbasiLos Angeles$556K
Peter WinkleCypress$116.7M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →